Suppr超能文献

术前治疗后直肠癌手术时机:是否需要前瞻性随机试验?

Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial?

机构信息

1 Departments of Surgery and Radiology, Royal Marsden Hospital, London, United Kingdom.

出版信息

Dis Colon Rectum. 2011 Oct;54(10):1251-9. doi: 10.1097/DCR.0b013e3182281f4b.

Abstract

BACKGROUND

In rectal cancer, the standard of care after the completion of radiotherapy is surgery at 6 to 8 weeks. However, there is variation regarding the timing of surgery.

OBJECTIVE

This investigation aimed to audit the timing of surgery following radiotherapy and to compare perioperative morbidity and tumor downstaging in patients operated on, before and after the 6- to 8-week window.

DESIGN

A retrospective review of rectal cancers treated preoperatively in our cancer network over a 27-month period. The effect of "time till surgery" of 6 to 8 weeks, <6 weeks, and >8 weeks on T downstaging and nodal downstaging was calculated by univariate and multivariate logistic regression analyses.

SETTING

This study was conducted in an oncology tertiary referral center in the Southwest London Cancer Network.

PATIENTS

Patients receiving preoperative radiotherapy for primary locally advanced rectal cancer undergoing subsequent surgical resection were eligible.

MAIN OUTCOME MEASURES

The primary outcome measurement was time to surgery following the completion of (chemo) radiotherapy. Thirty-day perioperative morbidity and mortality and tumor and nodal downstaging were examined according to the timing of surgery.

LIMITATIONS

This study was limited by its nonrandomized retrospective design and the lack of standardization of preoperative chemotherapy.

RESULTS

Thirty-two (34%) patients underwent surgery at 6 to 8 weeks, 45 (47%) at >8 weeks, and 18 (19%) at <6 weeks after radiotherapy. Delay was attributed to scheduling in 87% of cases and to comorbidities in the remainder. T downstaging occurred in 6 (33.3%) patients in the <6 weeks group, in 12 (37.5%) in the 6 to 8 weeks group, and in 28 (62.2%) in >8 weeks group with no significant differences in perioperative morbidity. On multivariate analysis, T downstaging was significantly greater for the >8 weeks group (OR, 3.79; 95% CI: 1.11-12.99; P = .03). More patients were staged ypT0-T2, 19 of 45 (42%) in the >8 weeks group vs other groups, 14 of 50 (28%, P < .05).

CONCLUSIONS

Following radiotherapy, surgery frequently occurs at >8 weeks and is associated with increased downstaging. The consequences on survival and perioperative morbidity warrant further investigation.

摘要

背景

在直肠癌中,放疗完成后的标准治疗方法是在 6 至 8 周后进行手术。然而,手术时机存在差异。

目的

本研究旨在审查放疗后手术的时机,并比较在 6 至 8 周窗口期前后进行手术的患者的围手术期发病率和肿瘤降期情况。

设计

对 27 个月内在我们癌症网络中接受术前治疗的直肠癌患者进行回顾性分析。通过单变量和多变量逻辑回归分析,计算“手术时间”为 6 至 8 周、<6 周和>8 周对 T 降期和淋巴结降期的影响。

设置

本研究在伦敦西南部癌症网络的一个肿瘤三级转诊中心进行。

患者

接受原发性局部晚期直肠癌术前放疗并随后接受手术切除的患者符合条件。

主要观察指标

完成(化疗)放疗后的手术时间。根据手术时机,检查 30 天围手术期发病率和死亡率以及肿瘤和淋巴结降期情况。

局限性

本研究受到其非随机回顾性设计和术前化疗缺乏标准化的限制。

结果

32 例(34%)患者在放疗后 6 至 8 周进行手术,45 例(47%)患者在>8 周进行手术,18 例(19%)患者在<6 周进行手术。87%的情况下延迟归因于安排,其余情况下归因于合并症。<6 周组有 6 例(33.3%)患者发生 T 降期,6 至 8 周组有 12 例(37.5%)患者发生 T 降期,>8 周组有 28 例(62.2%)患者发生 T 降期,围手术期发病率无显著差异。多变量分析显示,>8 周组 T 降期更为显著(OR,3.79;95%CI:1.11-12.99;P=.03)。>8 周组更多患者分期为 ypT0-T2,45 例中有 19 例(42%),而其他组有 14 例(28%,P<.05)。

结论

放疗后,手术经常在>8 周时进行,并与降期增加相关。对生存和围手术期发病率的影响需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验